Compare UNFI & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNFI | HTFL |
|---|---|---|
| Founded | 1976 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 1996 | 2025 |
| Metric | UNFI | HTFL |
|---|---|---|
| Price | $32.86 | $27.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $37.38 | ★ $39.50 |
| AVG Volume (30 Days) | ★ 1.2M | 617.5K |
| Earning Date | 12-02-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,753,000,000.00 | $161,881,000.00 |
| Revenue This Year | $2.54 | $40.42 |
| Revenue Next Year | $1.92 | $22.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.45 | ★ 85.70 |
| 52 Week Low | $20.78 | $25.75 |
| 52 Week High | $43.29 | $41.22 |
| Indicator | UNFI | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 40.32 | N/A |
| Support Level | $30.91 | N/A |
| Resistance Level | $35.11 | N/A |
| Average True Range (ATR) | 1.79 | 0.00 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 25.29 | 0.00 |
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.